BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 3403089)

  • 21. [Clinical evaluation of aztreonam (AZT) in the treatment of complicated urinary tract infections].
    Mizutani S; Iwao N; Miyoshi S; Kameoka H; Yano H; Kishimoto T; Sakurai T; Wakatsuki A; Nakamura T; Honda M
    Hinyokika Kiyo; 1989 Dec; 35(12):2155-61. PubMed ID: 2694836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clindamycin plus amikacin versus clindamycin plus aztreonam in established intraabdominal infections.
    Barboza E; del Castillo M; Yi A; Gotuzzo E
    Surgery; 1994 Jul; 116(1):28-35. PubMed ID: 8023265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
    Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
    J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aztreonam in gram-negative infections in children.
    Sklavunu-Tsurutsoglu S; Gatzola-Karaveli M; Hitoglu-Makedu A; Paradelis AG; Tsurutsoglu G
    Chemioterapia; 1987 Jun; 6(2 Suppl):415-7. PubMed ID: 3509461
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of the therapeutic efficacy of aztreonam in the treatment of infection caused by sensitive microorganisms].
    Tirone F; Musca G; Filomia D; Vigna L
    Riv Eur Sci Med Farmacol; 1989 Feb; 11(1):85-8. PubMed ID: 2798996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminoglycosides, imipenem, and aztreonam.
    Johnson JG; Hardin TC
    Clin Podiatr Med Surg; 1992 Apr; 9(2):443-64. PubMed ID: 1586911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of low dose aztreonam in the treatment of moderate to severe gram-negative bacterial infections.
    Clergeot A; Steru D; Rosset MA; Carbon C
    J Antimicrob Chemother; 1989 May; 23(5):753-8. PubMed ID: 2759924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical evaluation of the combination of carumonam and fosfomycin in the treatment of complicated urinary tract infection].
    Kakizaki H; Ishii N; Murakami S; Suzuki K; Takamizawa A; Hirano J; Mitobe K; Saito M; Hirano K; Imamura A
    Hinyokika Kiyo; 1990 Jun; 36(6):731-5. PubMed ID: 2239570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the clinical effectiveness of aztreonam in gram-negative infections of the biliary tract].
    Pedretti G; Magnani G
    G Ital Chemioter; 1988; 35(1-3):45-8. PubMed ID: 3256512
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of aztreonam in lower respiratory tract infections.
    Cook JL
    Urology; 1988 Jun; 31(6 Suppl):33-6. PubMed ID: 3287748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative multicenter study on efficacy and safety of aztreonam and gentamicin in prophylaxis of high-risk colorectal surgery.
    Dionigi R; Mozzillo N; Ventriglia L
    J Chemother; 1989 May; 1 Suppl 2():22-7. PubMed ID: 2681560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azthreonam in the treatment of urinary tract infection: evaluation of efficacy, renal effects and nephrotoxicity.
    Donadio C; Tramonti G; Garcea G; Lorusso P; Lucchetti A; Giordani R; Pierotti R; Falcone G; Bianchi C
    Drugs Exp Clin Res; 1987; 13(3):167-70. PubMed ID: 3622245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical evaluation of aztreonam in the prevention and therapy of infections in patients subjected to neurosurgical intervention].
    Donati PA; Gallicchio B; Maiuri F; Gangemi M; D'Andrea F
    Minerva Med; 1987 Aug; 78(16):1227-30. PubMed ID: 3627533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aztreonam: the first monobactam.
    Neu HC
    Med Clin North Am; 1988 May; 72(3):555-66. PubMed ID: 3280906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose tobramycin combined with clindamycin or lincomycin in the treatment of septic peritonitis and intraabdominal sepsis.
    Muth L; Edén T
    Acta Chir Scand; 1981; 147(5):339-46. PubMed ID: 7324760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience with aztreonam in four Mediterranean countries.
    Daikos GK
    Rev Infect Dis; 1985; 7 Suppl 4():S831-5. PubMed ID: 2934787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Aztreonam. A small-spectrum antibiotic in gram-negative infections].
    Sander J
    Tidsskr Nor Laegeforen; 1991 Aug; 111(18):2277-8. PubMed ID: 1896987
    [No Abstract]   [Full Text] [Related]  

  • 38. Imipenem and aztreonam.
    Sobel JD
    Infect Dis Clin North Am; 1989 Sep; 3(3):613-24. PubMed ID: 2671142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experience with aztreonam in Germany and Austria.
    Stille W; Gillissen J
    Rev Infect Dis; 1985; 7 Suppl 4():S825-30. PubMed ID: 3909342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
    Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
    Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.